Live from the NIH registry
Studies recruiting near Spartanburg right now
Top 25 of 362 recruiting studies, sorted by proximity — each links to its official registry page
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Spartanburg Medical Center — Spartanburg, South Carolina (0.5 mi)
· Sponsor: NRG Oncology
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Carolina Nephrology PA — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Amgen
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Greenville, South Carolina (27.3 mi)
· Sponsor: AstraZeneca
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Greenville, South Carolina (27.3 mi)
· Sponsor: Dren Bio
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Advanced Dermatology and Cosmetic Surgery - Spartanburg — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Celldex Therapeutics
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Spartanburg Medical Center — Spartanburg, South Carolina (0.5 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Prisma Health Cancer Institute - Spartanburg — Boiling Springs, South Carolina (7.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
St Francis Cancer Center /ID# 243596 — Greenville, South Carolina (27.3 mi)
· Sponsor: AbbVie
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Intracranial Aneurysm
N/A
Observational 118 participants sought
Prisma Health — Greenville, South Carolina (27.3 mi)
· Sponsor: Medtronic Neurovascular Clinical Affairs
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Prisma Health Greenville Memorial Hospital — Greenville, South Carolina (27.3 mi)
· Sponsor: Penumbra Inc.
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Tribe Clinical Research, LLC- Greer — Greer, South Carolina (17.1 mi)
· Sponsor: Pfizer
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Velocity Clinical Research - Spartanburg — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Altesa Biosciences, Inc.
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (27.3 mi)
· Sponsor: National Cancer Institute (NCI)
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Carolina Ottobock.care — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (27.3 mi)
· Sponsor: Children's Oncology Group
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Prisma Health-Upstate Cancer Institute — Greenville, South Carolina (27.3 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Prisma Health Maternal Fetal Medicine — Greenville, South Carolina (27.3 mi)
· Sponsor: Pfizer
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Tobacco Use, Substance Use Disorders
N/A
Interventional 240 participants sought
Phoenix Center — Greenville, South Carolina (27.3 mi)
· Sponsor: Medical University of South Carolina
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Spartanburg, South Carolina (0.5 mi)
· Sponsor: Medtronic
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Saint Francis Health System ( Site 0089) — Greenville, South Carolina (27.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Saint Francis Hospital — Greenville, South Carolina (27.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
Prisma Health Greer Memorial Hospital — Greer, South Carolina (17.1 mi)
· Sponsor: Pfizer
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Spartanburg, South Carolina (0.5 mi)
· Sponsor: GlaxoSmithKline
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Small Cell Lung Cancer Metastatic or Locally Advanced, Neuroendocrine Cancer
Phase 1
Interventional 120 participants sought
Prisma Health Cancer Institute — Greenville, South Carolina (27.3 mi)
· Sponsor: SystImmune Inc.